Solventum Corporation reaffirmed earnings guidance for its full-year 2024. For the period, Company expects Organic revenue growth of -2% to 0%.
Market Closed -
Other stock markets
|
After market 07:00:10 pm | |||
55.05 USD | -1.22% | 55.5 | +0.82% |
May. 30 | Goldman Sachs Initiates Solventum With Sell Rating, $54 Price Target | MT |
May. 09 | Solventum Q1 Adjusted Earnings Decline, Net Sales Increase | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 9.51B | |
+24.43% | 88.22B | |
-22.82% | 76.5B | |
+1.76% | 26.97B | |
+8.16% | 18.61B | |
-12.71% | 16.72B | |
+3.45% | 15.85B | |
+74.36% | 13.41B | |
+78.22% | 13.16B | |
+37.30% | 12.62B |
- Stock Market
- Equities
- SOLV Stock
- News Solventum Corporation
- Solventum Corporation Reaffirms Earnings Guidance for Its Full-Year 2024